Anna Smajdor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anna Smajdor has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Ruth Deech
9 shared publicationsDaniela Cutas
Clinical Sciences, Lund University, Lund, Sweden
6 shared publications- Jonathan Herring
Exeter College, University of Oxford
4 shared publications Andrea Stöckl
University of East Anglia
3 shared publications- Joona Räsänen
Department of Philosophy, Contemporary History and Political Science, & Turku Institute for Advanced Studies, University of Turku, Turku, Finland
3 shared publications Robert Wheeler
3 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in Theoretical Medicine and Bioethics
- Vol. 47 (6) , 523-541
Reification as a vice: rethinking bioethics beyond moral status
- 21 August 2026
- Published by Springer Nature in Theoretical Medicine and Bioethics
- Vol. 47 (6) , 523-541
Open AccessReification as a vice: rethinking bioethics beyond moral status
- Open Access
- 20 August 2026
- Published by Springer Nature in Health Care Analysis
- p. 1-16
Synthetic Medical Data vs. The Four Principles: Ethical Trade-Offs and Zombie Data
Rapid advances in AI for medical applications are accompanied by an increasing demand for vast datasets. Privacy constraints – legal restrictions such as GDPR, as well as more general ethical concerns – pose significant barriers to the acquisition and use of data. Synthetic medical data (SMD) is AI-generated data that mimics real patient information. SMD is being promoted as an ethical solution that preserves privacy while enabling scalable model training. However, as we will show, the use of SMD raises its own set of issues. SMD’s emphasis on privacy and scalability subtly embeds ethical and epistemic trade-offs that undermine the principles commonly regarded as being paramount in medical ethics. These trade-offs lack the kind of ethical justification one would expect in decisions that disrupt commonly accepted values and priorities, such as those captured by Beauchamp and Childress’ four principles. In the discourse on the ethical advantages of SMD, privacy tends to be treated as a value in its own right. We show that this is a problematic assumption. Transparency, privacy, scalability, and fidelity are all linked in complex ways with the principles of medical ethics. We map these relationships and show that when privacy is privileged over other values, it conflicts with autonomy and beneficence. Our aim here is not to establish that this privileging is wrong per se, but to show that it needs careful analysis before we can accept the idea that SMD is indeed ethically advantageous.
- 20 August 2026
- Published by Springer Nature in Health Care Analysis
- p. 1-16
Open AccessSynthetic Medical Data vs. The Four Principles: Ethical Trade-Offs and Zombie Data
Rapid advances in AI for medical applications are accompanied by an increasing demand for vast datasets. Privacy constraints – legal restrictions such as GDPR, as well as more general ethical concerns – pose significant barriers to the acquisition and use of data. Synthetic medical data (SMD) is AI-generated data that mimics real patient information. SMD is being promoted as an ethical solution that preserves privacy while enabling scalable model training. However, as we will show, the use of SMD raises its own set of issues. SMD’s emphasis on privacy and scalability subtly embeds ethical and epistemic trade-offs that undermine the principles commonly regarded as being paramount in medical ethics. These trade-offs lack the kind of ethical justification one would expect in decisions that disrupt commonly accepted values and priorities, such as those captured by Beauchamp and Childress’ four principles. In the discourse on the ethical advantages of SMD, privacy tends to be treated as a value in its own right. We show that this is a problematic assumption. Transparency, privacy, scalability, and fidelity are all linked in complex ways with the principles of medical ethics. We map these relationships and show that when privacy is privileged over other values, it conflicts with autonomy and beneficence. Our aim here is not to establish that this privileging is wrong per se, but to show that it needs careful analysis before we can accept the idea that SMD is indeed ethically advantageous.
- 5 July 2026
- Published by Taylor & Francis
- p. 59-80
Ectogenesis or Gestational Justice?
- Open Access
- 3 March 2026
- Published by Linkoping University Electronic Press in Northern European Journal of Language Technology
- Vol. 12 (1)
Assessing Moral Judgment by Large Language Models – A Survey of Available Datasets
Recent advances in language modeling have contributed to a growing emphasis on machine ethics, including researching and assessing moral judgments made by large language models (LLMs). This paper provides a critical survey of the existing datasets for exactly this assessment, with a special focus on the respective data sources. We address the current lack of theoretical grounding by providing an introduction to ethics and different frameworks from moral philosophy and moral psychology. Moreover, we identify four main data sources: webcrawled corpora, scholars, laypeople, and synthetic data generation. By discussing the strengths and weaknesses of these sources, we analyze their implications for the assessment of moral judgment. Importantly, systemizing the available datasets reveals an over-reliance on previous work, reinforcing existing shortcomings. Addressing the current limitations, we recommend adopting a consistent terminology and creating independently curated datasets based on interdisciplinary work. To ensure a clear delineation of normative approaches, we propose focusing on the assessment of moral consistency and certainty of LLMs as effective and well-defined indicators of their performance on moral judgment.
- 3 March 2026
- Published by Linkoping University Electronic Press in Northern European Journal of Language Technology
- Vol. 12 (1)
Open AccessAssessing Moral Judgment by Large Language Models – A Survey of Available Datasets
Recent advances in language modeling have contributed to a growing emphasis on machine ethics, including researching and assessing moral judgments made by large language models (LLMs). This paper provides a critical survey of the existing datasets for exactly this assessment, with a special focus on the respective data sources. We address the current lack of theoretical grounding by providing an introduction to ethics and different frameworks from moral philosophy and moral psychology. Moreover, we identify four main data sources: webcrawled corpora, scholars, laypeople, and synthetic data generation. By discussing the strengths and weaknesses of these sources, we analyze their implications for the assessment of moral judgment. Importantly, systemizing the available datasets reveals an over-reliance on previous work, reinforcing existing shortcomings. Addressing the current limitations, we recommend adopting a consistent terminology and creating independently curated datasets based on interdisciplinary work. To ensure a clear delineation of normative approaches, we propose focusing on the assessment of moral consistency and certainty of LLMs as effective and well-defined indicators of their performance on moral judgment.
- Open Access
- 2 January 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 26 (1) , 51-53
Whole Body Gestational Donation, and the Real Life Case of Adriana Smith
- 2 January 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 26 (1) , 51-53
Open AccessWhole Body Gestational Donation, and the Real Life Case of Adriana Smith
- Open Access
- 23 December 2025
- Published by Faculdade Jesuita de Filosofia e Teologia – FAJE in Síntese: Revista de Filosofia
- Vol. 52 (164) , 611
WHAT IS RIGHT FOR ‘THIS’ PATIENT? AUTONOMY, TRUST AND TRANSPARENCY IN THE ERA OF MEDICAL AI
In this paper we compare the capabilities and limitations of AI algorithms and human doctors in the context of treatment recommendations. Ethical concerns have been raised in the literature about transparency, accountability, and interpretability in relation to AI algorithms in the medical context. Patients’ autonomy is not likely to be respected if treatment recommendations are opaque or incomprehensible. Medical AI algorithms are programmed to prioritise predefined goals that may not align with patients’ preferences, potentially undermining their autonomy without their awareness. Yet human doctors often face similar challenges, such as reliance on clinical trial data with endpoints that may not be fully understood by patients. We conclude that there are opportunities now to integrate patient autonomy considerations into AI algorithms at the design stage, and that these goals and any relevant weightings are made explicit to end users, including both doctors and patients. Keywords: Artificial intelligence. Autonomy Alignment. Medical ethics.
- 23 December 2025
- Published by Faculdade Jesuita de Filosofia e Teologia – FAJE in Síntese: Revista de Filosofia
- Vol. 52 (164) , 611
Open AccessWHAT IS RIGHT FOR ‘THIS’ PATIENT? AUTONOMY, TRUST AND TRANSPARENCY IN THE ERA OF MEDICAL AI
In this paper we compare the capabilities and limitations of AI algorithms and human doctors in the context of treatment recommendations. Ethical concerns have been raised in the literature about transparency, accountability, and interpretability in relation to AI algorithms in the medical context. Patients’ autonomy is not likely to be respected if treatment recommendations are opaque or incomprehensible. Medical AI algorithms are programmed to prioritise predefined goals that may not align with patients’ preferences, potentially undermining their autonomy without their awareness. Yet human doctors often face similar challenges, such as reliance on clinical trial data with endpoints that may not be fully understood by patients. We conclude that there are opportunities now to integrate patient autonomy considerations into AI algorithms at the design stage, and that these goals and any relevant weightings are made explicit to end users, including both doctors and patients. Keywords: Artificial intelligence. Autonomy Alignment. Medical ethics.
- 7 May 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 52 (3) , 148-152
Synthetic DNA and mitochondrial donation: no need for donor eggs?
Mitochondrial replacement therapy has been developed in order to prevent the transmission of mitochondrial mutations, yet it raises ethical concerns, particularly regarding the involvement of third-party DNA and the risks associated with donor procedures. This paper explores an alternative approach using synthetic DNA (synDNA) to construct mitochondrial organelles, thereby bypassing the need for donor oocytes and bypassing risks to donors. We argue that those who support mitochondrial replacement techniques as an ethically acceptable means of preventing the transmission of mitochondrial disease should consider the use of synthetic mitochondria as a preferable ethical alternative, should it prove technically viable. That this will be viable is more than we can demonstrate here. However, progress in synDNA technology suggests that it is not unreasonable to think that synthetic mitochondria creation is feasible, and perhaps even probable.
- 7 May 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 52 (3) , 148-152
Synthetic DNA and mitochondrial donation: no need for donor eggs?
Mitochondrial replacement therapy has been developed in order to prevent the transmission of mitochondrial mutations, yet it raises ethical concerns, particularly regarding the involvement of third-party DNA and the risks associated with donor procedures. This paper explores an alternative approach using synthetic DNA (synDNA) to construct mitochondrial organelles, thereby bypassing the need for donor oocytes and bypassing risks to donors. We argue that those who support mitochondrial replacement techniques as an ethically acceptable means of preventing the transmission of mitochondrial disease should consider the use of synthetic mitochondria as a preferable ethical alternative, should it prove technically viable. That this will be viable is more than we can demonstrate here. However, progress in synDNA technology suggests that it is not unreasonable to think that synthetic mitochondria creation is feasible, and perhaps even probable.
- Open Access
- 21 March 2025
- Published by Cambridge University Press (CUP) in Hypatia
- p. 1-19
The Social Construction of Reproduction
In recent decades, ethicists have engaged with new developments in human reproductive technologies from a variety of angles. Yet there has been relatively little effort to problematize the concept of reproduction itself. In this paper, we examine the question of what reproduction is and its relationship with biology. We show that reproduction is commonly assumed to entail biological parenthood—an assumption that we term “the biological reproduction paradigm.” Drawing on Sally Haslanger’s analysis of the biological/social division between sex and gender, we suggest that the concept of reproduction is socially constructed, despite its apparently biological nature. In turn, we argue that the supposed necessity of the relationship between reproduction and biological parenthood leads to a situation in which access to a variety of medical, legal, and social goods is constrained on the basis of spurious, inconsistent, and undertheorized assumptions. Finally, we note that, given the socially constructed nature of reproduction, we cannot take it for granted that the term “reproduction” signifies the same thing among different interlocutors and in different contexts.
- 21 March 2025
- Published by Cambridge University Press (CUP) in Hypatia
- p. 1-19
Open AccessThe Social Construction of Reproduction
In recent decades, ethicists have engaged with new developments in human reproductive technologies from a variety of angles. Yet there has been relatively little effort to problematize the concept of reproduction itself. In this paper, we examine the question of what reproduction is and its relationship with biology. We show that reproduction is commonly assumed to entail biological parenthood—an assumption that we term “the biological reproduction paradigm.” Drawing on Sally Haslanger’s analysis of the biological/social division between sex and gender, we suggest that the concept of reproduction is socially constructed, despite its apparently biological nature. In turn, we argue that the supposed necessity of the relationship between reproduction and biological parenthood leads to a situation in which access to a variety of medical, legal, and social goods is constrained on the basis of spurious, inconsistent, and undertheorized assumptions. Finally, we note that, given the socially constructed nature of reproduction, we cannot take it for granted that the term “reproduction” signifies the same thing among different interlocutors and in different contexts.
- 23 February 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 51 (6) , 384-385
Why not coercive pronatalism?
- 23 February 2025
- Published by BMJ in Journal of Medical Ethics
- Vol. 51 (6) , 384-385
Why not coercive pronatalism?
- 20 November 2024
- Published by BMJ in Journal of Medical Ethics
The ethics of synthetic DNA
In this paper, we discuss the ethical concerns that may arise from the synthesis of human DNA. To date, only small stretches of DNA have been constructed, but the prospect of generating human genomes is becoming feasible. At the same time, the significance of genes for identity, health and reproduction is coming under increased scrutiny. We examine the implications of DNA synthesis and its impact on debates over the relationship with our DNA and the ownership of our genes, its potential to disrupt common understandings of reproduction and privacy, and the way in which synthetic DNA challenges traditional associations between genes and identity. We explore the degree to which synthetic DNA may further undermine overgeneticised accounts of identity, health, reproduction, parenthood and privacy that are prevalent in the public domain and in some areas of policy-making. While avoiding making normative claims of our own, we conclude that there is a need for reflection on the ethical implications of these developing technologies before they are on us.
- 20 November 2024
- Published by BMJ in Journal of Medical Ethics
The ethics of synthetic DNA
In this paper, we discuss the ethical concerns that may arise from the synthesis of human DNA. To date, only small stretches of DNA have been constructed, but the prospect of generating human genomes is becoming feasible. At the same time, the significance of genes for identity, health and reproduction is coming under increased scrutiny. We examine the implications of DNA synthesis and its impact on debates over the relationship with our DNA and the ownership of our genes, its potential to disrupt common understandings of reproduction and privacy, and the way in which synthetic DNA challenges traditional associations between genes and identity. We explore the degree to which synthetic DNA may further undermine overgeneticised accounts of identity, health, reproduction, parenthood and privacy that are prevalent in the public domain and in some areas of policy-making. While avoiding making normative claims of our own, we conclude that there is a need for reflection on the ethical implications of these developing technologies before they are on us.